Loading institutional data...
Loading institutional data...
Held by 627 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 26 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MSFT | $3.88T | 29.1× | 20.6× | 11.7× | 17.8% | 67.9% | 40.3% | 30.2% | 27.7% | 0.1× | 2,407 |
| PLTR | $442.4B | 292.2× | — | 98.9× | 56.2% | 82.4% | 36.3% | 22.0% | 22.0% | -1.0× | 1,128 |
| ORCL | $396.1B | 22.4× | 13.2× | 5.9× | 17.3% | — | 25.4% | 40.2% | 34.4% | -0.8× | 1,233 |
| CRWD | $256.4B | — | — | 53.3× | 21.7% | 74.7% | -3.4% | -3.7% | -3.1% | — | 951 |
| SHOP | $202.6B | 167.5× | 134.2× | 17.5× | 30.1% | 48.1% | 10.7% | 9.1% | 9.1% | -1.0× | 575 |
| CRM | $188.6B | 29.4× | 20.5× | 4.5× | 9.6% | 77.7% | 18.0% | 12.6% | 10.1% | 0.8× | 896 |
| NOW | $109.1B | 63.0× | 41.7× | 8.2× | 20.9% | 77.5% | 13.2% | 13.5% | 12.1% | -0.9× | 745 |
| SNOW | $108.0B | — | — | 23.1× | 29.2% | 67.2% | -28.4% | -69.2% | -69.2% | — | 464 |
| NET | $100.0B | — | — | 46.1× | 29.8% | 74.5% | -4.7% | -7.0% | -7.0% | — | 390 |
| ADBE | $97.4B | 15.0× | 10.3× | 4.1× | 10.5% | 89.3% | 30.0% | 61.3% | 40.0% | 0.1× | 627 |
| INTU | $91.2B | 20.7× | 15.5× | 4.3× | 13.9% | — | 21.3% | 24.0% | 17.1% | 0.5× | 532 |
| CDNS | $90.0B | 80.8× | 50.6× | 17.0× | 14.1% | — | 20.9% | 20.3% | 20.3% | -1.8× | 390 |
| SNPS | $89.6B | 58.2× | 63.6× | 12.7× | 15.1% | 77.0% | 18.9% | 4.7% | 3.2% | 6.7× | 389 |
| DDOG | $84.5B | — | — | 24.6× | 27.7% | 80.0% | 3.1% | 2.9% | 2.9% | — | 350 |
| NTES | $72.8B | 75.8× | 12.1× | 4.5× | 11.6% | 64.3% | 30.9% | 21.7% | 21.7% | -1.2× | 101 |
| EA | $52.9B | 59.7× | 36.3× | 7.0× | 0.9% | 79.0% | 11.8% | 13.1% | 13.1% | -2.1× | 2 |
| ADSK | $52.2B | 47.7× | 32.3× | 7.2× | 17.5% | 91.0% | 15.6% | 36.9% | 20.3% | 0.1× | 339 |
| VEEV | $50.7B | 57.5× | — | 15.9× | 16.3% | 75.5% | 28.4% | 12.6% | 12.6% | — | 342 |
| XYZ | $45.8B | 36.3× | 22.4× | 1.9× | 0.3% | 42.8% | 5.4% | 5.9% | 4.4% | 0.3× | 289 |
| OKTA | $36.4B | 159.0× | — | 12.5× | 11.8% | 77.4% | 8.1% | 3.4% | 3.4% | -5.3× | 249 |
| TTWO | $35.6B | — | — | 5.3× | 18.2% | 57.2% | -4.5% | -8.5% | -4.9% | 10.3× | 276 |
| TWLO | $31.5B | — | 90.0× | 6.2× | 13.7% | 48.9% | 0.7% | 0.4% | 0.4% | 0.9× | 290 |
| RBLX | $30.7B | — | — | 6.3× | 35.8% | 78.1% | -21.8% | -270% | -76.0% | — | 184 |
| CRWV | $30.3B | — | 20.1× | 5.9× | 168% | 71.7% | -22.7% | -35.0% | -4.7% | 7.6× | 269 |
| MDB | $28.4B | — | — | 11.5× | 22.8% | 71.7% | -2.9% | -2.4% | -2.4% | — | 220 |
Peers = companies sharing ADBE's sector (Services-Prepackaged Software) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $11.28B buybacks = $11.28B returned on $9.85B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 40%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The same 3 years as the 3-yr average, with the stock compensation of those years charged as a cost. Shares issued to employees are real dilution, so this asks what the business generates for existing holders.
To be worth $250.23 today, the market must believe free cash flow compounds 3.2%/yr for a decade (off $6.39B on the SBC-adjusted basis).
On the basis ($8.22B) the requirement is -0.2%/yr. The difference is what charging stock compensation costs.
The market's 3.2% is more conservative than its 9-yr track record.
Default is 9.5% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.39B shares (market data) · net debt $779.0M
mean 20.5% · volatility σ 19% · implied rate exceeded in 6/9 yrs
Central path = implied 3.2%/yr growth; shaded band = ±1σ (19%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.2% on $6.21B of debt.
Cash of $5.43B fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2020 | FY2019 | FY2018 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.77B 100.0% | $21.50B 100.0% | $19.41B 100.0% | $17.61B 100.0% | $15.79B 100.0% | $12.87B 100.0% | $11.17B 100.0% | $9.03B 100.0% | $7.30B 100.0% | $5.85B 100.0% |
| Cost of Revenue | $2.55B 10.7% | $2.36B 11.0% | $2.35B 12.1% | $2.17B 12.3% | $1.86B 11.8% | $1.72B 13.4% | $1.67B 15.0% | $1.20B 13.2% | $1.01B 13.8% | $819.9M 14.0% |
| Cost of Products | — | — | — | — | — | — | — | — | $57.1M 0.8% | $68.9M 1.2% |
| Cost of Services | — | — | — | — | — | — | — | — | $330.4M 4.5% | $289.1M 4.9% |
| Gross Profit | $21.22B 89.3% | $19.15B 89.0% | $17.05B 87.9% | $15.44B 87.7% | $13.92B 88.2% | $11.15B 86.6% | $9.50B 85.0% | $7.83B 86.8% | $6.29B 86.2% | $5.03B 86.0% |
| Selling, General & Admin | $1.57B 6.6% | $1.53B 7.1% | $1.41B 7.3% | $1.22B 6.9% | $1.08B 6.9% | $968.0M 7.5% | $881.0M 7.9% | $745.0M 8.3% | $624.7M 8.6% | $576.2M 9.8% |
| Total Operating Expenses | $12.51B 52.6% | $12.41B 57.7% | $10.40B 53.6% | $9.34B 53.1% | $8.12B 51.4% | $6.91B 53.7% | $6.23B 55.8% | $5.00B 55.3% | $4.12B 56.5% | $3.54B 60.5% |
| Operating Income | $8.71B 36.6% | $6.74B 31.3% | $6.65B 34.3% | $6.10B 34.6% | $5.80B 36.8% | $4.24B 32.9% | $3.27B 29.3% | $2.84B 31.5% | $2.17B 29.7% | $1.49B 25.5% |
| Interest Expense | $263.0M 1.1% | $169.0M 0.8% | $113.0M 0.6% | $112.0M 0.6% | $113.0M 0.7% | $116.0M 0.9% | $157.0M 1.4% | $89.0M 1.0% | $74.4M 1.0% | $70.4M 1.2% |
| Interest & Investment Income | $264.0M 1.1% | $341.0M 1.6% | $269.0M 1.4% | $61.0M 0.3% | $17.0M 0.1% | $43.0M 0.3% | $68.0M 0.6% | $93.0M 1.0% | $66.1M 0.9% | $47.3M 0.8% |
| Other Income (Expense), net | $28.0M 0.1% | $190.0M 0.9% | $149.0M 0.8% | -$90.0M -0.5% | -$97.0M -0.6% | -$61.0M -0.5% | -$63.0M -0.6% | -$46.0M -0.5% | -$30.5M -0.4% | -$58.5M -1.0% |
| Pretax Income | $8.73B 36.7% | $6.93B 32.2% | $6.80B 35.0% | $6.01B 34.1% | $5.71B 36.1% | $4.18B 32.5% | $3.21B 28.7% | $2.79B 30.9% | $2.14B 29.3% | $1.44B 24.5% |
| Income Tax Expense | $1.60B 6.7% | $1.37B 6.4% | $1.37B 7.1% | $1.25B 7.1% | $883.0M 5.6% | -$1.08B -8.4% | $254.0M 2.3% | $203.0M 2.2% | $443.7M 6.1% | $266.4M 4.5% |
| Net Income | $7.13B 30.0% | $5.56B 25.9% | $5.43B 28.0% | $4.76B 27.0% | $4.82B 30.5% | $5.26B 40.9% | $2.95B 26.4% | $2.59B 28.7% | $1.69B 23.2% | $1.17B 20.0% |
| Per Share | ||||||||||
| EPS (Basic) | $16.73 | $12.43 | $11.87 | $10.13 | $10.10 | $10.94 | $6.07 | $5.28 | $3.43 | $2.35 |
| EPS (Diluted) | $16.70 | $12.36 | $11.82 | $10.10 | $10.02 | $10.83 | $6.00 | $5.20 | $3.38 | $2.32 |
| Weighted Avg Shares (Basic) | 426.2M | 447.1M | 457.1M | 469.5M | 477.3M | 480.9M | 486.3M | 490.6M | 493.6M | 498.3M |
| Weighted Avg Shares (Diluted) | 427.0M | 449.7M | 459.1M | 470.9M | 481.0M | 485.5M | 491.6M | 497.8M | 501.1M | 504.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 11th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 61% against ROIC 40% — 21% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 55.4% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.8× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 13.2 | 15.0 | 13.4 | 11.8 | 12.3 | 12.1 | 11.0 | 10.7 |
| Gross Profit | 86.8 | 85.0 | 86.6 | 88.2 | 87.7 | 87.9 | 89.0 | 89.3 |
| SG&A | 8.3 | 7.9 | 7.5 | 6.9 | 6.9 | 7.3 | 7.1 | 6.6 |
| Operating Income | 31.5 | 29.3 | 32.9 | 36.8 | 34.6 | 34.3 | 31.3 | 36.6 |
| Income Tax | 2.2 | 2.3 | -8.4 | 5.6 | 7.1 | 7.1 | 6.4 | 6.7 |
| Net Income | 28.7 | 26.4 | 40.9 | 30.5 | 27.0 | 28.0 | 25.9 | 30.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ADBE: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 41.88pts above its cost of capital, positive in 5 of the last 5 years.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 21.5% | 9.5% (today's — no rate published for this year) | 12.0pts |
| FY2020 | 24.8% | 9.5% (today's — no rate published for this year) | 15.3pts |
| FY2022 | 29.3% | 5.3% | 24.0pts |
| FY2023 | 33.2% | 9.8% | 23.4pts |
| FY2024 | 38.7% | 10.7% | 28.0pts |
| FY2024 | 41.8% | 10.7% | 31.1pts |
| FY2025 | 52.7% | 9.1% | 43.6pts |
| Now | 40.0% | 9.5% | 30.5pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2017 | 86.0% | 25.5% | 20.0% |
| FY2018 | 86.2% | 29.7% | 23.2% |
| FY2018 | 86.8% | 31.5% | 28.7% |
| FY2019 | 85.0% | 29.3% | 26.4% |
| FY2020 | 86.6% | 32.9% | 40.9% |
| FY2022 | 88.2% | 36.8% | 30.5% |
| FY2023 | 87.7% | 34.6% | 27.0% |
| FY2024 | 87.9% | 34.3% | 28.0% |
| FY2024 | 89.0% | 31.3% | 25.9% |
| FY2025 | 89.3% | 36.6% | 30.0% |
Leverage and buybacks account for 21 points of the 61% return on equity in FY2025. The business earns 40% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Converts 1.41x of reported profit into free cash flow over 5 years, with accruals negative.
Reported free cash flow is $9.85B; after share-based compensation it is $7.91B. The difference is a real cost that the cash flow statement adds back.
Covers interest 23.2x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 33.10x |
| 5% | 31.45x |
| 10% | 29.79x |
| 15% | 28.14x |
| 20% | 26.48x |
| 25% | 24.83x |
| 30% | 23.17x |
| 35% | 21.52x |
| 40% | 19.86x |
| 45% | 18.21x |
| 50% | 16.55x |
| 55% | 14.90x |
| 60% | 13.24x |
Balance sheet at 2025-11-28. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
At $250.23, free cash flow must compound 3.25%/yr for 10 years. It has done 16.05%/yr over 6 years after stock compensation.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 35.8% | 3.2% |
| FY2022 | 32.1% | 3.2% |
| FY2023 | 2.5% | 3.2% |
| FY2024 | −12.3% | 3.2% |
| FY2024 | 15.6% | 3.2% |
| FY2025 | 31.0% | 3.2% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
This is solved on free cash flow AFTER stock compensation ($6.39B against $8.22B before it). On the unadjusted figure the requirement would be -0.18%/yr. Which is right depends on whether you think the share issuance is a recurring cost of running the business.
| Step | Amount | Running total |
|---|---|---|
| Net income | $7.13B | $7.13B |
| Share-based comp | $1.94B | $9.07B |
| Other non-cash & working capital | $959M | $10.03B |
| Operating cash flow | $10.03B | $10.03B |
| Capex | −$179M | $9.85B |
| Free cash flow | $9.85B | $9.85B |
| FCF after SBC | $7.91B | $7.91B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 15.2% | -8.9% | -24.1 points |
| FY2022 | 22.7% | 34.3% | 11.7 points |
| FY2023 | 11.5% | 10.0% | -1.6 points |
| FY2024 | 10.2% | 7.7% | -2.5 points |
| FY2024 | 10.8% | -6.8% | -17.6 points |
| FY2025 | 10.5% | 13.1% | 2.6 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 50.2 days | not reported | 45.6 days | 4.6 days |
| FY2020 | 39.7 days | not reported | 64.9 days | -25.2 days |
| FY2022 | 43.4 days | not reported | 61.1 days | -17.6 days |
| FY2023 | 42.8 days | not reported | 63.9 days | -21.1 days |
| FY2024 | 41.8 days | not reported | 48.7 days | -6.9 days |
| FY2024 | 35.2 days | not reported | 55.9 days | -20.7 days |
| FY2025 | 36 days | not reported | 59.7 days | -23.7 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -7.1 percent |
| FY2020 | -1.9 percent |
| FY2022 | -8.8 percent |
| FY2023 | -11.3 percent |
| FY2024 | -6.3 percent |
| FY2024 | -8.3 percent |
| FY2025 | -9.8 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Option exercise | 769 | $0.00 | $0 |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Option exercise | 1,229 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers President, CXO | Option exercise | 760 | $0.00 | $0 |
| 2026-10-15 | 15 co-filers SVP & CAO | Option exercise |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| 60 |
| $0.00 |
| $0 |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Option exercise | 54 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers Chair and CEO | Option exerciseindirect | 2,200 | $0.00 | $0 |
| 2026-10-15 | 3 co-filers Chief Legal Officer & EVP | Option exercise | 1,308 | $0.00 | $0 |
| 2026-10-15 | 15 co-filers SVP & CAO | Tax withholding | 29 | $251.67 | $7k |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Tax withholding | 26 | $251.67 | $7k |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Tax withholding | 609 | $251.67 | $153k |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Tax withholding | 381 | $251.67 | $96k |
| 2026-10-15 | 12 co-filers President, CXO | Tax withholding | 376 | $251.67 | $95k |
| 2026-10-15 | 12 co-filers Chair and CEO | Tax withholdingindirect | 1,090 | $251.67 | $274k |
| 2026-10-15 | 3 co-filers Chief Legal Officer & EVP | Tax withholding | 648 | $251.67 | $163k |
| 2026-10-15 | 15 co-filers SVP & CAO | Option exercise | 35 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers President, CXO | Option exercise | 437 | $0.00 | $0 |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Option exercise | 1,308 | $0.00 | $0 |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Option exercise | 62 | $0.00 | $0 |
| 2026-10-15 | 3 co-filers Chief Legal Officer & EVP | Option exercise | 1,308 | $0.00 | — |
| 2026-10-15 | 12 co-filers Chair and CEO | Option exerciseindirect | 1,265 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Option exercise | 443 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Tax withholding | 219 | $251.67 | $55k |
| 2026-10-15 | 12 co-filers Chair and CEO | Tax withholdingindirect | 627 | $251.67 | $158k |
| 2026-10-15 | 12 co-filers President, CXO | Tax withholding | 216 | $251.67 | $54k |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Tax withholding | 648 | $251.67 | $163k |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Tax withholding | 30 | $251.67 | $8k |
| 2026-10-15 | 15 co-filers SVP & CAO | Tax withholding | 17 | $251.67 | $4k |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Option exercise | 152 | $0.00 | $0 |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Option exercise | 1,229 | $0.00 | — |
| 2026-10-15 | 12 co-filers President, CXO | Option exercise | 695 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Option exercise | 724 | $0.00 | $0 |
| 2026-10-15 | 15 co-filers SVP & CAO | Option exercise | 22 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers Chair and CEO | Option exerciseindirect | 1,978 | $0.00 | $0 |
| 2026-10-15 | 12 co-filers President, CXO | Tax withholding | 344 | $251.67 | $87k |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Tax withholding | 358 | $251.67 | $90k |
| 2026-10-15 | 12 co-filers Chair and CEO | Tax withholdingindirect | 980 | $251.67 | $247k |
| 2026-10-15 | 15 co-filers Interim CFO and SVP | Tax withholding | 75 | $251.67 | $19k |
| 2026-10-15 | 6 co-filers Chief Marketing Officer & EVP | Option exercise | 1,308 | $0.00 | — |
| 2026-10-15 | 15 co-filers SVP & CAO | Tax withholding | 10 | $251.67 | $3k |
| 2026-10-15 | 12 co-filers EVP, Chief People Officer | Option exercise | 1,308 | $0.00 | $0 |